{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:55:40Z","timestamp":1790420140612,"version":"4.1.0"},"reference-count":268,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"INOMAT"},{"name":"NanoBioss"},{"name":"Brazilian Network on Nanotoxicology"},{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The National Agency of Scientific and Technological Promotion"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.actatropica.2017.02.019","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T02:00:18Z","timestamp":1487728818000},"page":"16-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Nanopharmaceuticals as a solution to neglected diseases: Is it possible?"],"prefix":"10.1016","volume":"170","author":[{"given":"German A.","family":"Islan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano L.","family":"Cacicedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata K.T.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego S.T.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo R.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2017.02.019_bib0005","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4363751","article-title":"Investigation of the larvicidal potential of silver nanoparticles against Culex quinquefasciatus: a case of a ubiquitous weed as a useful bioresource","author":"Adesuji","year":"2016","journal-title":"J. Nanomat."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0010","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bbagen.2013.10.038","article-title":"Interaction of metal nanoparticles with recombinant arginine kinase from Trypanosoma brucei: thermodynamic and spectrofluorimetric evaluation","volume":"1840","author":"Adeyemi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0015","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","article-title":"Advances in nanomedicines for malaria treatment","volume":"201\u2013202","author":"Aditya","year":"2013","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0020","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0025","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejps.2010.10.002","article-title":"Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting","volume":"42","author":"Alex","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0030","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1517\/17425247.2013.771630","article-title":"Nanopharmaceuticals to target antifilarials: a comprehensive review","volume":"10","author":"Ali","year":"2013","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0035","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00436-013-3696-5","article-title":"Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model","volume":"113","author":"Ali","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0040","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1166\/jbn.2007.029","article-title":"Lipid nano spheres (lnss) for enhanced oral bioavailability of amphotericin b: development and characterization","volume":"3","author":"Amarji","year":"2007","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0045","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.01.009","article-title":"Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions","volume":"337","author":"Ara\u00fajo","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0050","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2014.11.002","article-title":"Nanobody conjugated PLGA nanoparticles for active targeting of African trypanosomiasis","volume":"197","author":"Arias","year":"2015","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0055","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/ac015675e","article-title":"Biosensor for dengue virus detection: sensitive, rapid, and serotype-specific","volume":"74","author":"Baeumner","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0060","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/10611860500285439","article-title":"Use of liposomized tetracycline in elimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model","volume":"13","author":"Bajpai","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0065","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0070","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.exppara.2013.03.035","article-title":"Trypanocidal activity of the essential oils in their conventional and nanoemulsion forms: in vitro tests","volume":"134","author":"Baldissera","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0075","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MCP.0b013e32835eff08","article-title":"Advances in nanotechnology for diagnosis and treatment of tuberculosis","volume":"19","author":"Banyal","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"11","key":"10.1016\/j.actatropica.2017.02.019_bib0080","doi-asserted-by":"publisher","first-page":"e890","DOI":"10.1371\/journal.pntd.0000890","article-title":"Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards","volume":"4","author":"Beatty","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0085","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1128\/AAC.40.6.1467","article-title":"Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes\/macrophages in vitro","volume":"40","author":"Bender","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0090","doi-asserted-by":"publisher","first-page":"17471754","DOI":"10.1007\/s00436-016-4971-z","article-title":"Declining malaria, rising dengue and Zika virus: insights for mosquito vector control","volume":"115","author":"Benelli","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0095","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1007\/s00436-015-4800-9","article-title":"Plant mediated biosynthesis of nanoparticles as an emerging tool against mosquitoes of medical and veterinary importance: a review","volume":"115","author":"Benelli","year":"2016","journal-title":"Parasitol. Res."},{"issue":"10","key":"10.1016\/j.actatropica.2017.02.019_bib0100","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"Bern","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0105","unstructured":"Bern, G., 2015. http:\/\/www.uptodate.com\/contents\/chagas-disease-antitrypanosomal-drug-therapy, accessesd on 12\/07\/2015."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0110","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.addr.2008.03.013","article-title":"Biological properties of naked metal nanoparticles","volume":"60","author":"Bhattacharya","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0115","first-page":"2940","article-title":"Nanocrystal technology and drug delivery","volume":"3","author":"Bhuyan","year":"2014","journal-title":"World J. Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0120","doi-asserted-by":"publisher","first-page":"e0004173","DOI":"10.1371\/journal.pntd.0004173","article-title":"Polyanhydride nanoparticle delivery platform dramatically enhances killing of filarial worms","volume":"9","author":"Binnebose","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0125","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cap.2004.06.011","article-title":"Mycobacterial formulation in liposomes showed decreased expression of CD95\/CD95L and caspase activity in T cells of leprosy patients","volume":"5","author":"Bisht","year":"2005","journal-title":"Curr. Appl. Phys."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0130","first-page":"535","article-title":"Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation","volume":"8","author":"Borges","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0135","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1021\/ja710321g","article-title":"Inhibition of HIV fusion with multivalent gold nanoparticles","volume":"130","author":"Bowman","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.actatropica.2017.02.019_bib0140","doi-asserted-by":"publisher","first-page":"e2847","DOI":"10.1371\/journal.pntd.0002847","article-title":"In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticles","volume":"8","author":"Carneiro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0145","first-page":"1219","article-title":"Differential effect of amphotericin B on the three evolutive stages of Trypanosoma cruzi and on the host cell-parasite interaction","volume":"26","author":"Castro","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1166\/rase.2014.1064","article-title":"Mechanism and applications of metal nanoparticles prepared by bio-mediated process","volume":"3","author":"Castro","year":"2014","journal-title":"Rev. Adv. Sci. Eng."},{"issue":"3","key":"10.1016\/j.actatropica.2017.02.019_bib0155","article-title":"Bionanoparticles, a green nanochemistry approach","volume":"16","author":"Cauerhff","year":"2013","journal-title":"Electron. J. Biotechnol."},{"issue":"6","key":"10.1016\/j.actatropica.2017.02.019_bib0160","doi-asserted-by":"publisher","first-page":"e1216","DOI":"10.1371\/journal.pntd.0001216","article-title":"Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome","volume":"5","author":"Cencig","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0165","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1995-7645(11)60150-8","article-title":"A review of neglected tropical diseases: filariasis","volume":"4","author":"Chandy","year":"2001","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0170","first-page":"386","article-title":"Liposomal delivery of Mycobacterium leprae antigen(s) with murabutide and Trat peptide inhibits Fas-mediated apoptosis of peripheral blood mononuclear cells derived from leprosy patients","volume":"44","author":"Chattree","year":"2007","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0175","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.antiviral.2009.08.003","article-title":"Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes","volume":"84","author":"Clayton","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0180","doi-asserted-by":"publisher","first-page":"638429","DOI":"10.1155\/2012\/638429","article-title":"Elimination of Onchocerca volvulus transmission in the Huehuetenango focus of Guatemala","volume":"2012","author":"Cruz-Ortiz","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0185","article-title":"New anti-tuberculosis drugs and regimens: 2015 update","volume":"1","author":"D\u2019Ambrosio","year":"2015","journal-title":"Eur. Resp. Soc. (ERJ) Open Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0190","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/10611860903450007","article-title":"Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach","volume":"18","author":"Dangi","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0195","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.colsurfb.2013.01.061","article-title":"One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis","volume":"107","author":"Das","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0200","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0205","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0168-3659(00)00272-8","article-title":"Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state","volume":"68","author":"De Jaeghere","year":"2000","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0210","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0166-3542(02)00002-5","article-title":"Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes","volume":"54","author":"De Mareuil","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0215","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1011050209986","article-title":"Targeting of 3\u2019-azido 3\u2019-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues","volume":"18","author":"Dembri","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0220","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","article-title":"TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis","volume":"185","author":"Demento","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0225","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0230","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S2222-1808(13)60035-3","article-title":"Evaluation of larvicidal activity of biogenic nanoparticles against filariasis causing culex mosquito vector","volume":"3","author":"Dhanasekaran","year":"2013","journal-title":"Asian Pac. J. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0235","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.bbagen.2007.12.010","article-title":"Inhibition of bfl-1\/A1 by siRNA inhibits mycobacterial growth in THP-1 cells by enhancing phagosomal acidification","volume":"1780","author":"Dhiman","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","article-title":"Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers \u2013 A systematic review of in vitro data","volume":"87","author":"Doktorovova","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0245","doi-asserted-by":"publisher","first-page":"151","DOI":"10.15171\/apb.2015.022","article-title":"Solid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughs","volume":"5","author":"Dolatabadi","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0250","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3109\/17435390.2015.1124468","article-title":"A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics","volume":"10","author":"Donnellan","year":"2016","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0255","doi-asserted-by":"publisher","first-page":"320","DOI":"10.18433\/J3R30T","article-title":"Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations","volume":"13","author":"Doroud","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0260","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-3024.2011.01289.x","article-title":"Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL\/6 mice","volume":"33","author":"Doroud","year":"2011","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0265","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bjp.2015.02.010","article-title":"Evaluation of larvicidal activity of a nanoemulsion of Rosmarinus officinalis essential oil","volume":"25","author":"Duarte","year":"2015","journal-title":"Rev. Brasil. Farmacogn."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0270","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/20014091096747","article-title":"Chromobacterium violaceum: a review on pharmacological and industrial perspectives","volume":"27","author":"Dur\u00e1n","year":"2001","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0275","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2174\/157341309789378069","article-title":"State of the art of nanobiotechnology applications in neglected diseases","volume":"5","author":"Dur\u00e1n","year":"2009","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0280","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1590\/S0100-40422010000100028","article-title":"Nanocrystal technologies in pharmaceuticals","volume":"33","author":"Dur\u00e1n","year":"2010","journal-title":"Quim. Nova"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0285","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1590\/S0103-50532010000600002","article-title":"Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action","volume":"21","author":"Dur\u00e1n","year":"2010","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0290","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00253-011-3249-8","article-title":"Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi and plants","volume":"90","author":"Dur\u00e1n","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0295","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1049\/iet-nbt.2014.0054","article-title":"Catalytic role of traditional enzymes for biosynthesis of biogenic metallic nanoparticles: a mini-review","volume":"9","author":"Dur\u00e1n","year":"2015","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0300","first-page":"1139","article-title":"Nanobiotechnology solutions against aedes aegypti","volume":"27","author":"Dur\u00e1n","year":"2016","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0305","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.nano.2015.11.016","article-title":"Antimicrobial activity mechanisms of silver nanoparticles: an overview","volume":"12","author":"Dur\u00e1n","year":"2016","journal-title":"Nanomed. NBM"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0310","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1007\/s00253-016-7657-7","article-title":"Antimicrobial activity of biogenic silver nanoparticles and silver chloride nanoparticles: an overview and comments","volume":"100","author":"Dur\u00e1n","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0315","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.colsurfb.2014.12.052","article-title":"Arteether nanoemulsion for enhanced efficacy against Plasmodium yoeliinigeriensis malaria: an approach by enhanced bioavailability","volume":"126","author":"Dwivedi","year":"2015","journal-title":"Colloids Surf. B Biointerfases"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0320","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arabjc.2010.04.008","article-title":"Synthesis and applications of silver nanoparticles","volume":"3","author":"El-Nour","year":"2010","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0325","first-page":"19","article-title":"Nanotechnology and nanomedicine applications in parasitic diseases","volume":"3","author":"El-Tonsy","year":"2010","journal-title":"Parasitol. United J."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0330","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.exppara.2014.12.007","article-title":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","volume":"149","author":"El-Zawawy","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0335","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-3155-3-6","article-title":"Interaction of silver nanoparticles with HIV-1","volume":"3","author":"Elechiguerra","year":"2005","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0340","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1590\/S0074-02761999000400010","article-title":"Protection against toxoplasmosis in mice immunized with different antigens of Toxoplasma gondii incorporated into liposomes","volume":"94","author":"Elsaid","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz (Rio de Janeiro)"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0345","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1590\/S0074-02762001000100011","article-title":"Vertical toxoplasmosis in a murine model: protection after immunization with antigens of Toxoplasma gondii incorporated into liposomes","volume":"96","author":"Elsaid","year":"2001","journal-title":"Mem. Inst. Oswaldo Cruz (Rio de Janeiro)"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0350","first-page":"82","article-title":"Development of a brazilian nanoencapsulated drug for schistosomiasis treatment","volume":"1","author":"Fonseca","year":"2013","journal-title":"Vigil Sanit\u00e1ria Debate"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0355","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/mren.201200036","article-title":"Production of PMMA nanoparticles loaded with praziquantel through in situ miniemulsion polymerization","volume":"7","author":"Fonseca","year":"2013","journal-title":"Macromol. React. Eng."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0360","first-page":"91","article-title":"Evaluation of the schistomicidal efficacy of lipossome-entrapped oxamniquine","volume":"39","author":"Fr\u00e9zard","year":"1997","journal-title":"J. Inst. Med. Trop. (S\u00e3o Paulo)"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0365","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.actatropica.2013.06.011","article-title":"Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay","volume":"128","author":"Frezza","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0370","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/nnm.13.7","article-title":"Polymer\u2013peptide hybrids as a highly immunogenic single-dose nanovaccine","volume":"9","author":"Fuaad","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0375","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.bmc.2015.01.033","article-title":"The use of a conformational cathepsin D-derived epitope for vaccine development against Schistosoma mansoni","volume":"23","author":"Fuaad","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0380","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","article-title":"Chitosan and silver nanoparticles: promising anti-toxoplasma agents","volume":"143","author":"Gaafar","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0385","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","article-title":"HIV Coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality","volume":"181","author":"Gandhi","year":"2010","journal-title":"Amer. J. Resp. Crit. Care Med."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0390","first-page":"997","article-title":"Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis","volume":"44","author":"Garg","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0395","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12257-010-0331-5","article-title":"Paromomycin loaded solid lipid nanoparticles: characterization of production parameters","volume":"16","author":"Ghadiri","year":"2011","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0400","first-page":"S321","article-title":"Formulation and characterization of plant essential oil based nanoemulsion: evaluation of its larvicidal activity against Aedes aegypti","volume":"25","author":"Ghosh","year":"2013","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0405","doi-asserted-by":"publisher","first-page":"a017798","DOI":"10.1101\/cshperspect.a017798","article-title":"Global epidemiology of tuberculosis","volume":"5","author":"Glaziou","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0410","doi-asserted-by":"publisher","first-page":"A143","DOI":"10.1089\/aid.2014.5288.abstract","article-title":"Nanodelivery of CSIC for enhanced solubility and rapid macrophage uptake","volume":"30","author":"Gong","year":"2014","journal-title":"AIDS Res. Hum. Retr."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0415","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0939-6411(99)00076-4","article-title":"Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosoma-tropic carrier: preparation and trypanocidal activity","volume":"49","author":"Gonz\u00e1lez-Mart\u00edn","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0420","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-008-0857-y","article-title":"Leprosy: diagnostic and control challenges for a worldwide disease","volume":"300","author":"Goulart","year":"2008","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0425","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21691401.2016.1228664","article-title":"Single-step biological fabrication of colloidal silver nanoparticles using Hugonia mystax: larvicidal potential against Zika virus, dengue, and malaria vector mosquitoes","author":"Govindarajan","year":"2016","journal-title":"Art. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0430","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jphotobiol.2016.07.036","article-title":"One-pot biogenic fabrication of silver nanocrystals using Quisqualis indica: effectiveness on malaria and Zika virus mosquito vectors, and impact on non-target aquatic organisms","volume":"162","author":"Govindarajan","year":"2016","journal-title":"J. Photochem. Photobiol. B: Biol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0435","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00436-016-5038-x","article-title":"One-step synthesis of polydispersed silver nanocrystals using Malva sylvestris: an eco-friendly mosquito larvicide with negligible impact on non-target aquatic organisms","volume":"115","author":"Govindarajan","year":"2016","journal-title":"Parasitology Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0440","first-page":"503","article-title":"Molluscicidal effects of nano-silver biological molluscicide and niclosamide","volume":"25","author":"Guang","year":"2013","journal-title":"Chin. J. Schistosomiasis Control."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0445","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.addr.2009.11.021","article-title":"Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs","volume":"62","author":"Gunaseelan","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0450","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0009-2797(89)90092-6","article-title":"Amphotericin B-induced damage of Trypanosoma cruzi epimastigotes","volume":"71","author":"Haido","year":"1989","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0455","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","article-title":"Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles","volume":"26","author":"Ham","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0460","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1023\/A:1012117531448","article-title":"Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake","volume":"14","author":"Hawley","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0465","first-page":"1","article-title":"Nanotechnology and the diagnosis\/treatment of leishmaniasis","volume":"55","author":"Henriques","year":"2014","journal-title":"Ars. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0470","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/157488511798109637","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review","volume":"6","author":"Hirlekar","year":"2011","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0475","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/thno.9128","article-title":"Malaria theranostics using hemozoin-generated vapor nanobubbles","volume":"4","author":"Hleb","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0480","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/QCO.0b013e328315cde7","article-title":"Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis","volume":"21","author":"Hoerauf","year":"2008","journal-title":"Curr. Opin. Infec. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0485","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","article-title":"Novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice","volume":"33","author":"Hunsawong","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0490","first-page":"1110","article-title":"Nano-gold particles mediated detection of ns1; an early diagnostic marker of dengue virus infection","volume":"24","author":"Hussain","year":"2014","journal-title":"J. Anim. Plant Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0495","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S2221-1691(13)60057-X","article-title":"RNAi: antiviral therapy against dengue v\u00edrus","volume":"3","author":"Idrees","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0500","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/08982104.2010.539185","article-title":"Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice","volume":"21","author":"Isacchi","year":"2011","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0505","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against. Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0510","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ijbiomac.2014.09.020","article-title":"Development of biopolymer nanocomposite for silver nanoparticles and ciprofloxacin controlled release","volume":"72","author":"Islan","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0515","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.colsurfb.2016.03.040","article-title":"Smart lipidic nanoparticles containing levofloxacin and DNase for lung delivery: design and characterization","volume":"143","author":"Islan","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0520","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1038\/srep03851","article-title":"Rapid immunoglobulin M-based dengue diagnostic test using surface plasmon resonance biosensor","volume":"4","author":"Jahanshahi","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0525","first-page":"123","article-title":"Nanoemulsion: an advanced mode of drug delivery system","volume":"5","author":"Jaiswal","year":"2015","journal-title":"3 Biotechnology"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0530","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1517\/17425247.2015.1086745","article-title":"Intracellular delivery of nanocarriers and targeting to subcellular organelles","volume":"13","author":"Jhaveri","year":"2016","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0535","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejps.2009.02.021","article-title":"Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics","volume":"37","author":"Jung","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0540","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajps.2014.08.005","article-title":"Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs","volume":"10","author":"Junyaprasert","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0545","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3109\/02652049409034992","article-title":"A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation","volume":"11","author":"Karajgi","year":"1994","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0550","first-page":"5","article-title":"Targeted delivery of diethylcarbamazine citrate to the lymphatics using solid lipid nanoparticles","volume":"6","author":"Karthik","year":"2014","journal-title":"J. Bioequiv. Availab."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0555","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jconrel.2014.04.009","article-title":"Nanostructured drug delivery for better management of tuberculosis","volume":"184","author":"Kaur","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0560","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2014008285","article-title":"Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis","volume":"31","author":"Kaur","year":"2014","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0565","first-page":"9202","article-title":"Pharmaceutical nanoemulsions an ardent carrier for drug delivery","volume":"3","author":"Kela","year":"2013","journal-title":"Indo Am. J. Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0570","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.2174\/138161281941131219135458","article-title":"Nanotechnological strategies for the treatment of neglected diseases","volume":"19","author":"Khalil","year":"2013","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0575","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1517\/17425247.2014.889678","article-title":"Development of targeted 1, 2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis","volume":"11","author":"Khatik","year":"2014","journal-title":"Exp. Op. Drug Del."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0580","first-page":"735","article-title":"Drug delivery sytems in the treatment of african trypanomiasis infections","volume":"6","author":"Kroubi","year":"2015","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0585","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijpharm.2006.07.044","article-title":"Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate\u2013sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood\u2013brain barrier","volume":"327","author":"Kuo","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.actatropica.2017.02.019_bib0590","first-page":"850","article-title":"Dengue vaccine: local decisions, global consequences","volume":"94","author":"L\u00f3pez-Gatell","year":"2016","journal-title":"Bull. WHO"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0595","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0939-6411(97)00078-7","article-title":"Body distribution of azidothymidine bound to nanoparticles after oral administration","volume":"44","author":"L\u00f6benberg","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0600","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0168-3659(97)00105-3","article-title":"Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats","volume":"50","author":"L\u00f6benberg","year":"1998","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0605","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11904-010-0054-4","article-title":"New antituberculous drugs in development","volume":"7","author":"Lalloo","year":"2010","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0610","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2011.02.006","article-title":"Pulmonary delivery of therapeutic siRNA","volume":"64","author":"Lam","year":"2012","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0615","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijpharm.2005.10.004","article-title":"Development of parenteral formulations and evalutions of the biological activity of the trypanocide drug benznidazole","volume":"307","author":"Lamas","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0620","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3851\/IMP1684","article-title":"Nanoparticulate delivery systems for antiviral drugs","volume":"21","author":"Lembo","year":"2010","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0625","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/jps.2600841202","article-title":"Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice","volume":"84","author":"Leroux","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0630","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/00001432-199310000-00008","article-title":"Fungal and parasitic skin infestations \u2013 an update in treatment","volume":"6","author":"Leslie","year":"1993","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0635","first-page":"647","article-title":"Effects of nanoparticles in cells infected by Toxoplasma gondii","volume":"12","author":"Leyke","year":"2013","journal-title":"e-Polymers"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0640","first-page":"493","article-title":"Preparation and characterization of poli(\u03b5-caprolactone) nanoparticles containing megazol: antichagasic agent","volume":"93","author":"Lima","year":"2012","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0645","first-page":"69","article-title":"Review of the current treatments for leishmaniases","volume":"3","author":"Lindoso","year":"2012","journal-title":"Res. Reports Trop. Med."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0650","first-page":"104","article-title":"Determination of encapsulation efficiency and release of baicalein solid lipid nanoparticles in vitro","volume":"12","author":"Liu","year":"2009","journal-title":"Pract. Pharm. Clin. Rem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0655","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ejps.2011.09.017","article-title":"Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis","volume":"45","author":"Lopes","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0660","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1166\/jbn.2014.1874","article-title":"Liposomes versus lipid nanoparticles: comparative study of lipid-based systems as oryzalin carriers for the treatment of leishmaniasis","volume":"10","author":"Lopes","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0665","doi-asserted-by":"publisher","first-page":"626","DOI":"10.4236\/jbnb.2011.225075","article-title":"Current state of nanoemulsions in drug delivery","volume":"2","author":"Lovelyn","year":"2011","journal-title":"J. Biomat. Nanobiotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0670","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jinorgbio.2010.08.009","article-title":"Dithiocarbazate complexes with the [M(PPh3)]2+ (M=Pd or Pt) moiety: synthesis, caracterization and anti-Tripanosoma cruzi activity","volume":"104","author":"Maia","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0675","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02652040400026285","article-title":"Praziquantel-loaded PLGA nanoparticles: preparation and characterization","volume":"22","author":"Mainardes","year":"2005","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0680","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1166\/jnn.2006.487","article-title":"Development of praziquantel-loadd PLGA nanoparticles and evaluation of intestinal permeation by the everted gut Sac model","volume":"6","author":"Mainardes","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0685","doi-asserted-by":"publisher","first-page":"e0003527","DOI":"10.1371\/journal.pntd.0003527","article-title":"Health economic evaluations of visceral leishmaniasis treatments: a systematic review","volume":"9","author":"Marinho","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0690","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2014.05.038","article-title":"Respirable nanocarriers as a promising strategy for antitubercular drug delivery","volume":"187","author":"Mehanna","year":"2014","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0695","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013005469","article-title":"Nanomedicines for treatment of viral diseases","volume":"30","author":"Mehendale","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0700","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0378-5173(03)00125-X","article-title":"Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes","volume":"255","author":"Melo","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0705","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.addr.2014.05.018","article-title":"siRNA delivery to the lung: what's new?","volume":"75","author":"Merkel","year":"2014","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0710","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/515085","article-title":"U.S. food and drug administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0715","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1128\/AAC.01554-12","article-title":"Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo","volume":"56","author":"Miller","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0720","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.exppara.2006.04.004","article-title":"Trypanosoma cruzi: oxidative stress induces arginine kinase expression","volume":"114","author":"Miranda","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0725","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/351693","article-title":"Intestinal lymphatic delivery of praziquantel by solid lipid nanoparticles: formulation design, in vitro and in vivo studies","author":"Mishra","year":"2014","journal-title":"J. Nanotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0730","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0014-5793(94)00351-3","article-title":"Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes","volume":"344","author":"Moghimi","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0735","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jac\/47.1.101","article-title":"Cure of experimental Chagas' disease by the bis-triazole D0870 incorporated into \u2018stealth' polyethyleneglycol-polylactide nanospheres","volume":"47","author":"Molina","year":"2001","journal-title":"J. Antimicrob. Chemoth."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0740","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/08982104.2012.762519","article-title":"Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis","volume":"23","author":"Momeni","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0745","first-page":"5175","article-title":"Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies","volume":"7","author":"Monteiro","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0750","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.exppara.2014.04.013","article-title":"Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice","volume":"143","author":"Moosavian Kalat","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0755","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.inhe.2010.04.002","article-title":"The role of product development partnerships in research and development for neglected diseases","volume":"2","author":"Moran","year":"2010","journal-title":"Intern. Health"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0760","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.nano.2015.07.011","article-title":"Assessment of \u03b2-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB\/c mice","volume":"11","author":"Moreno","year":"2015","journal-title":"Nanomed. NBM"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0765","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijpharm.2005.02.009","article-title":"Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes","volume":"295","author":"Mour\u00e3o","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0770","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1086\/382048","article-title":"Targeting of parasite specific immunoliposome-encapulated doxorubicin in the treatment of experimental visceral leishmaniasis","volume":"189","author":"Mukherjee","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0775","first-page":"1","article-title":"The laboratory diagnosis of dengue virus infection, a review","volume":"4","author":"Mungrue","year":"2014","journal-title":"Adv. Lab. Med. Int."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0780","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1007\/s00436-015-4638-1","article-title":"Seaweed synthesized silver nanoparticles: an ecofriendly tool in the fight against Plasmodium falciparum and its vector Anopheles stephensi?","volume":"114","author":"Murugan","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0785","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1007\/s00436-015-4676-8","article-title":"Nanoparticles in the fight against mosquitoborne diseases: bioactivity of Bruguiera cylindricasynthesized nanoparticles against dengue virus DEN2 (in vitro) and its mosquito vector Aedes aegypti (Diptera: culicidae)","volume":"114","author":"Murugan","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0790","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00436-015-4783-6","article-title":"Fighting arboviral diseases: low toxicity on mammalian cells, dengue growth inhibition (in vitro) and mosquitocidal activity of Centroceras clavulatum synthesized silver nanoparticles","volume":"115","author":"Murugan","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0795","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.rvsc.2016.03.001","article-title":"In vivo and in vitro effectiveness of Azadirachta indica synthesized silver nanocrystals against Plasmodium berghei and Plasmodium falciparum, and their potential against malaria mosquitoes","volume":"106","author":"Murugan","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0800","doi-asserted-by":"publisher","first-page":"16671","DOI":"10.1007\/s11356-016-6832-9","article-title":"Ecofriendly drugs from the marine environment: spongeweed synthesized silver nanoparticles are highly effective on Plasmodium falciparum and its vector Anopheles stephensi, with little non target effects on predatory copepods","volume":"16","author":"Murugan","year":"2016","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0805","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for Leishmaniasis and human African Trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0810","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1021\/nn5054206","article-title":"Nanomimics of host cell membranes block invasion and expose invasive malaria parasites","volume":"8","author":"Najer","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0815","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/molecules20021872","article-title":"Natural products as leads in schistosome drug discovery","volume":"20","author":"Neves","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0820","first-page":"932","article-title":"Preliminary formulation and characterization of solid lipid nanoparticles containing chloroquine and a P-glycoprotein inhibitor: influences of lipid-surfactant ratios","volume":"7","author":"Nzekwe","year":"2015","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0825","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/1061186021000001832","article-title":"Lipid-drug conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate","volume":"10","author":"Olbrich","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0830","doi-asserted-by":"publisher","first-page":"e3379","DOI":"10.1371\/journal.pntd.0003379","article-title":"A changing model for developing health products for poverty-related infectious diseases","volume":"9","author":"Olliaro","year":"2015","journal-title":"PLOS Neglect. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0835","first-page":"3865","article-title":"Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles","volume":"9","author":"Omwoyo","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0840","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1128\/AAC.39.1.180","article-title":"Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium Berghei infections in mice","volume":"39","author":"Owais","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0845","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10611860310001620707","article-title":"Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental brugian filariasis","volume":"11","author":"Owais","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0850","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ajps.2014.06.005","article-title":"Drug\/polymer nanoparticles prepared using unique spray nozzles and recent progress of inhaled formulation","volume":"9","author":"Ozeki","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0855","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/jac\/dki027","article-title":"Antitubercular inhaled therapy: opportunities, progress and challenges","volume":"55","author":"Pandey","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0860","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.biopha.2005.06.011","article-title":"Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations","volume":"59","author":"Papagiannaros","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0865","first-page":"1","article-title":"Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity","volume":"44","author":"Parashar","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0870","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/026520499289077","article-title":"Encapsulation and stability of clofazimine liposomes","volume":"16","author":"Patel","year":"1999","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0875","first-page":"448","article-title":"A topical dosage form of liposomal clofazimine: research and clinical implications","volume":"54","author":"Patel","year":"1999","journal-title":"Pharmazie"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0880","first-page":"806","article-title":"Current and nano-diagnostic tools for dengue infection","volume":"3","author":"Peh","year":"2013","journal-title":"Front. Biosci. (Scholar Ed.)"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0885","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1678-9199-19-34","article-title":"Challenges and perspectives of Chagas disease: a review","volume":"19","author":"Pereira","year":"2013","journal-title":"J. Venom. Anim. Toxin. Incl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0890","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0035-9203(79)90103-2","article-title":"Liposomes in the chemotherapy of experimental murine malaria","volume":"73","author":"Pieson","year":"1979","journal-title":"T. Roy Soc. Trop. Med. Health"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0895","first-page":"3501","article-title":"The disposition of free and liposomally encapsulated antimalarial primaquine in mice","volume":"21","author":"Pieson","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0900","first-page":"504","article-title":"Application of pharmaceutical nanotechnology to the treatment of malaria","volume":"43","author":"Pimentel","year":"2007","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0905","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00436-013-3715-6","article-title":"Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis","volume":"113","author":"Pissinate","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0910","doi-asserted-by":"publisher","first-page":"17176","DOI":"10.1073\/pnas.1009445107","article-title":"Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells","volume":"107","author":"Pollock","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0915","unstructured":"Ponder, E., 2012. Global Health Primer 2012 Snapshot."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0920","first-page":"1001","article-title":"Polymeric nanoparticles for targeted treatment in oncology: current insights","volume":"10","author":"Prabhu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0925","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/0019-5154.74528","article-title":"Leprosy therapy, past and present: can we hope to eliminate it?","volume":"55","author":"Prasad","year":"2010","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0930","first-page":"531","article-title":"A critical review on biogenic silver nanoparticles and their antimicrobial activity","volume":"4","author":"Prasad","year":"2001","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0935","first-page":"161","article-title":"Nanotechnology based drug delivery system","volume":"1","author":"Qureshi","year":"2011","journal-title":"J. Pharm. Res. Opin."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0940","series-title":"Metal Nanoparticles in Microbiology","first-page":"330","year":"2011"},{"key":"10.1016\/j.actatropica.2017.02.019_bib0945","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00253-013-5473-x","article-title":"Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects","volume":"98","author":"Rai","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0950","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1515\/ntrev-2014-0001","article-title":"Nanosilver: an inorganic nanoparticle with myriad potential applications","volume":"3","author":"Rai","year":"2014","journal-title":"Nanotechnol. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0955","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.actatropica.2011.03.003","article-title":"Larvicidal activity of synthesized silver nanoparticles using Eclipta prostrata leaf extract against filariasis and malaria vectors","volume":"118","author":"Rajakumar","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0960","doi-asserted-by":"publisher","first-page":"100","DOI":"10.18433\/J3M59P","article-title":"Present status of nanoparticle research for treatment of tuberculosis","volume":"14","author":"Ranjita","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0965","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/jps.21970","article-title":"Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery","volume":"99","author":"Rao","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0970","first-page":"B46","article-title":"In vivo pharmacokinetic stydies of albendazole nanoparticulate oral formulation for improve bioavailability","volume":"2","author":"Ravichandran","year":"2010","journal-title":"Int. J. Green Nanotechnol. Biomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0975","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/AAC.00223-08","article-title":"Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate","volume":"52","author":"Ribeiro","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0980","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0985","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0990","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/489758","article-title":"Experimental vaccines against Chagas disease: a journey through history","author":"Rodr\u00edguez-Morales","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib0995","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejps.2015.01.015","article-title":"Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis","volume":"70","author":"Rodrigues Caldeira","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1000","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tube.2010.11.004","article-title":"Local pulmonary immunotherapy with siRNA targeting TGFb1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice","volume":"91","author":"Rosas-Taraco","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1005","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4028\/www.scientific.net\/JNanoR.20.89","article-title":"Therapeutic potential of biogenic silver nanoparticles in murine cutaneous leishmaniasis","volume":"20","author":"Rossi-Bergmann","year":"2012","journal-title":"J. Nano. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1010","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.carbpol.2015.11.007","article-title":"Carbohydrate polymer inspired silver nanoparticles for filaricidal and mosquitocidal activities: a comprehensive view","volume":"137","author":"Saha","year":"2016","journal-title":"Carbohyd. Polym."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1015","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejpb.2011.12.015","article-title":"Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches","volume":"81","author":"Salazar","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1020","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/jps.23010","article-title":"First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery sytems","volume":"101","author":"Salomon","year":"2012","journal-title":"J. Pharma. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1025","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00436-011-2328-1","article-title":"Larvicidal potential of silver nanoparticles synthesized using fungus Cochliobolus lunatus against Aedes aegypti (Linnaeus, 1762) and Anopheles stephensi Liston (Diptera; Culicidae)","volume":"109","author":"Salunkhe","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1030","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1590\/S0100-40422012000700019","article-title":"Development and characterization of lipid nanoparticles for dapsone topical application","volume":"35","author":"Santos","year":"2012","journal-title":"Quim. Nova"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1035","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Santos-Magalh\u00e3es","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1040","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tim.2010.04.003","article-title":"Targeting a host process as na antiviral approach against dengue virus","volume":"18","author":"Sayce","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1045","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/AAC.45.6.1771-1779.2001","article-title":"Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplamosis","volume":"45","author":"Scholer","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1050","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/B:JIPH.0000011734.89838.bc","article-title":"Amphiphilic cyclodextrin complexation of Clofazimine","volume":"47","author":"Schwinte","year":"2013","journal-title":"J. Inclus. Phenom. Macrocyclic. Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1055","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/bm4000822","article-title":"Hydrolytic activities of crystalline cellulose nanofibers","volume":"14","author":"Serizawa","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1060","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1007\/s11095-006-9101-7","article-title":"Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV\/AIDS","volume":"23","author":"Shah","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1065","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2147\/IJN.S77837","article-title":"Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA","volume":"10","author":"Shao","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1070","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1075","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/10611861003733995","article-title":"SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood\u2013brain barriers","volume":"19","author":"Shubar","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1080","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-10-13","article-title":"A tetravalent dengue nanoparticle stimulates antibody production in mice","volume":"10","author":"Silva","year":"2012","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1085","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1021\/acs.molpharmaceut.6b00206","article-title":"Subcutaneously administered ultrafine PLGA nanoparticles containing doxycycline hydrochloride target lymphatic filarial parasites","volume":"13","author":"Singh","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1090","series-title":"In Patenting Nanomedicines: Legal Aspects, Intellectual Properties and Grant Opportunities","first-page":"401","article-title":"Nanomedicine in malaria","author":"Singh","year":"2012"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1095","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/nyas.12618","article-title":"Modeling malaria in humanized mice","volume":"1342","author":"Siu","year":"2015","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1100","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1021\/mp200209j","article-title":"Cocrystals of quercetin with improved solubility and oral bioavailability","volume":"8","author":"Smith","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1105","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00436-011-2467-4","article-title":"Efficacy of fungus mediated silver and gold nanoparticles against Aedes aegypti larvae","volume":"110","author":"Soni","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1110","first-page":"1","article-title":"Synthesis of gold nanoparticles by the fungus Aspergillus niger and its efficacy against mosquito larvae","volume":"2","author":"Soni","year":"2012","journal-title":"Rep. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1115","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00436-012-3056-x","article-title":"Fungal-mediated nano silver: an effective adulticide against mosquito","volume":"111","author":"Soni","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1120","doi-asserted-by":"publisher","first-page":"S356","DOI":"10.1016\/S2222-1808(12)60181-9","article-title":"Entomopathogenic fungus generated nanopart icles for enhancement of efficacy in Culex quinquefasciatus and Anopheles stephensi","volume":"2","author":"Soni","year":"2012","journal-title":"Asian Pacif. J. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1125","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4236\/anp.2013.22021","article-title":"Possible mosquito control by silver nanoparticles synthesized by soil fungus (Aspergillus niger 2587)","volume":"2","author":"Soni","year":"2013","journal-title":"Adv. Nanopart."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1130","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.addr.2009.11.023","article-title":"New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery","volume":"62","author":"Sosnik","year":"2010","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1135","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijpharm.2013.12.022","article-title":"In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment","volume":"46","author":"Souza","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1140","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejmech.2015.03.022","article-title":"Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles","volume":"95","author":"Souza","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0102-695X2012005000128","article-title":"Development and characterization of PLGA nanocapsules of grandisin isolated from Virola surinamensis: in vitro release and cytotoxicity studies","volume":"23","author":"Stecanella","year":"2013","journal-title":"Braz. J. Pharmacog."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1150","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0378-5173(00)00338-0","article-title":"Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design","volume":"198","author":"Stensrud","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1155","doi-asserted-by":"publisher","first-page":"7543","DOI":"10.1007\/s11356-015-6007-0","article-title":"Multipurpose effectiveness of Couroupita guianensis synthesized gold nanoparticles: high antiplasmodial potential, field efficacy against malaria vectors and synergy with Aplocheilus lineatus predators","volume":"23","author":"Subramaniam","year":"2016","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1160","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00436-012-3269-z","article-title":"Green synthesis of silver nanoparticles using Murraya koenigii leaf extract against Anopheles stephensi and Aedes aegypti","volume":"112","author":"Suganya","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1165","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00436-015-4556-2","article-title":"Greensynthesized silver nanoparticles as a novel control tool against dengue virus (DEN2) and its primary vector Aedes aegypti","volume":"114","author":"Sujitha","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1170","doi-asserted-by":"publisher","first-page":"e0003397","DOI":"10.1371\/journal.pntd.0003397","article-title":"A literature review of economic evaluations for a neglected tropical disease: human african Trypanosomiasis (\u201cSleeping Sickness\u201d)","volume":"9","author":"Sutherland","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1175","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2307\/3282665","article-title":"Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes","volume":"76","author":"Tachibana","year":"1990","journal-title":"J. Parasitol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1180","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/rmv.461","article-title":"Trends in dengue diagnosis","volume":"15","author":"Teles","year":"2005","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1185","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1995-7645(14)60115-2","article-title":"Review of age-old antimalarial drug to combat malaria: efficacy up- gradation by nanotechnology based drug delivery","volume":"7","author":"Tripathy","year":"2014","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1190","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijpharm.2012.05.064","article-title":"Synthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: a dose and duration dependent approach","volume":"434","author":"Tripathy","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1195","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.actatropica.2013.07.011","article-title":"A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection","volume":"128","author":"Tripathy","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1200","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1205","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijpharm.2011.12.009","article-title":"Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting","volume":"423","author":"Tsai","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1210","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1371\/journal.pntd.0000660","article-title":"Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulusin an area of Loa loacoendemicity: a randomized controlled trial","volume":"4","author":"Turner","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1215","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/imj.12638","article-title":"Leprosy: diagnosis and management in a developed setting","volume":"45","author":"Turner","year":"2015","journal-title":"Internal Med. J."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1220","first-page":"1","article-title":"Recent advances in particulate anti-malarial drug delivery systems. A review","volume":"5","author":"Umeyor","year":"2013","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1004942","article-title":"Specific cell targeting therapy bypasses drug resistance mechanisms in African Trypanosomiasis","volume":"11","author":"Unciti-Broceta","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1230","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new end TB strategy?","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1235","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/00001432-200112000-00012","article-title":"Specific treatment of Chagas\u2019 disease: current status and new developments","volume":"14","author":"Urbina","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1240","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2011.08.016","article-title":"PLGA nanoparticles loaded with the antileishmanial saponin \u03b2-aescin: factor influence study and in vitro efficacy evaluation","volume":"420","author":"Van de Ven","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1245","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s00436-014-4077-4","article-title":"Adulticidal properties of synthesized silver nanoparticles using leaf extracts of Feronia elephantum (Rutaceae) against filariasis, malaria, and dengue vector mosquitoes","volume":"113","author":"Veerakumar","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1250","series-title":"Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1255","series-title":"TDR at a Glance","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1260","series-title":"Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1265","series-title":"World Health Organization","author":"WHO","year":"2014"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1270","series-title":"Lepra","author":"WHO","year":"2015"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1275","series-title":"Onchocerciasis","author":"WHO","year":"2015"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1280","unstructured":"WHO\/HTM\/TB, 2014.08. Geneva, World Health Organization, 2014."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1285","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis. A review","volume":"111","author":"Wang","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1290","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.colsurfb.2015.04.013","article-title":"Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis","volume":"130","author":"Want","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1295","series-title":"Ph.D. Dissertation","article-title":"Emerging technologies for the poor: how nanomedicine and public private partnerships are used to address diseases of poverty","author":"Woodson","year":"2014"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1300","first-page":"656","article-title":"Lymphatic filariasis. an overview","volume":"8","author":"Yadav","year":"2014","journal-title":"Glob. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1305","first-page":"86","article-title":"Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles","volume":"64","author":"Yang","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1310","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4028\/www.scientific.net\/AMR.399-401.527","article-title":"Controlled synthesis of water soluble silver nanoparticles and the molluscicidal effect","volume":"399\u2013401","author":"Yang","year":"2011","journal-title":"Adv. Mat. Res."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1315","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-0172","article-title":"Global and regional burden of isoniazid-resistant tuberculosis","volume":"136","author":"Yuen","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1320","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1472-6882-12-214","article-title":"Novel antiviral activity of baicalein against dengue v\u00edrus","volume":"12","author":"Zandi","year":"2012","journal-title":"BMC Complem. Alternat. Med."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1325","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.snb.2010.02.021","article-title":"Silicon nanowire biosensor for highly sensitive and rapid detection of Dengue virus","volume":"146","author":"Zhang","year":"2010","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.actatropica.2017.02.019_bib1330","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1039\/C4LC01127A","article-title":"A stacking flow immunoassay for the detection of dengue-specific immunoglobulins in salivary fluid","volume":"15","author":"Zhang","year":"2015","journal-title":"Lab Chip"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1335","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1021\/bm500229d","article-title":"Synthesis of cellulose nanocrystals carrying tyrosine sulfate mimetic ligands and inhibition of alphavirus infection","volume":"15","author":"Zoppe","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actatropica.2017.02.019_bib1340","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(13)62078-4","article-title":"WHO\u2019s 2013 global report on tuberculosis: successes, threats, and opportunities","volume":"382","author":"Zumla","year":"2013","journal-title":"Lancet"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16301917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16301917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T23:26:52Z","timestamp":1568849212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X16301917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":268,"alternative-id":["S0001706X16301917"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2017.02.019","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanopharmaceuticals as a solution to neglected diseases: Is it possible?","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2017.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}